in Health care
Novo Nordisk to cut US list prices for several insulin products by up to 75 percent next year
U.S. : Novo Nordisk said on Tuesday it would cut U.S. list prices for several insulin products by up to 75% next year, joining rival Eli Lilly and Co as political pressure mounts to make these life-sustaining diabetes treatments more affordable. The moves follow the passing of President Joe Biden’s Inflation Reduction Act last year that […] More
